Basic Information (Switzerland) Elecon Asia SA (hereinafter referred to as “Elecon”) is a powerful intelligent three-d...
Digital Copyright Ten Major Typical Cases 1.Short Video Copyright Case: Whether a Short Video is Original Has Nothing to...
December 7, 2023 - News of a patent infringement ruling against Apple Watches a few weeks ago caused a flurry of investo...
's claim in the dispute over Targin. For years, Frankfurt-based Mundipharma defended market exclusivity for its painkiller Targin against various generic drug manufacturers. The product combines two
Generic drug companies cannot launch their enzalutamide products in the Netherlands. In the pan-European dispute over prostate cancer drug Xtandi, the District Court The Hague upheld a basic patent
the corresponding originator drug is marketed under the brand name Jevtana®. This ruling marks a key development in the patent dispute between Sanofi and multiple generic drug manufacturers over
total 1 pages, 3 items
CHINA intellectual PROPERTY LAWYERS NETWORK
+86-13910160652
ciplawyers@163.com
